RAYNAUD'S DISEASE

Clinical trials for RAYNAUD'S DISEASE explained in plain language.

Never miss a new study

Get alerted when new RAYNAUD'S DISEASE trials appear

Sign up with your email to follow new studies for RAYNAUD'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

An open label study to assess efficacy of oral treprostinil titrated to 3.0mg three times daily or highest tolerable dose in 30 patients with symptomatic primary or secondary Raynaud's phenomenon resistant to standard vasodilatory therapy

Recruiting now

Raynaud's phenomenon is a condition where the blood vessels in participants fingers and toes get too narrow when cold or stressed. This makes participants fingers and toes change colors - they might turn white, then blue, and finally red as blood flow returns. It can be painful a…

Matched conditions: RAYNAUD'S DISEASE

Phase: PHASE4 • Sponsor: Brigham and Women's Hospital

Last updated Mar 30, 2026 14:28 UTC

RAYNAUD'S DISEASE

Get alerted when new RAYNAUD'S DISEASE trials appear

An open label study to assess efficacy of oral treprostinil titrated to 3.0mg three times daily or highest tolerable dose in 30 patients with symptomatic primary or secondary Raynaud's phenomenon resistant to standard vasodilatory therapy